Study Evaluating Pneumococcal Meningitis in the Paediatric Population in Spain Four Years After the Marketing of Prevenar. - Full Text View

Sponsored by:	Wyeth
Information provided by:	Wyeth
ClinicalTrials.gov Identifier:	NCT00227214

Purpose

The aim of this study is to determine the prevalence of pneumococcal meningitis in the paediatric population in Spain four years after the marketing of Prevenar. Also secondary objectives are: 1) to determine the clinical characteristics and outcome of the disease; and 2) to determine serotypes and antibiotic resistance patterns.

Condition
Pneumococcal Meningitis

MedlinePlus related topics: Meningitis

Drug Information available for: Heptavalent pneumococcal conjugate vaccine Pneumococcal Vaccines

U.S. FDA Resources

Study Type:	Observational
Study Design:	Natural History, Longitudinal, Defined Population, Prospective Study
Official Title:	Prevalence of Pneumococcal Meningitis in the Paediatric Population in Spain Four Years After the Marketing of Prevenar.

Further study details as provided by Wyeth:

Estimated Enrollment:	500
Study Start Date:	January 2004

Eligibility

Ages Eligible for Study:	up to 14 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

All children from 0 up to 14 years with diagnosis of confirmed or probable pneumococcal meningitis or with diagnosis of suspected bacterial meningitis without bacterial or viral isolation will be included into the study.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00227214

Contacts

Contact: Trial Manager

clintrialparticipation@wyeth.com

Locations

Spain
	Recruiting
Alcalá de Henares, Spain
	Not yet recruiting
Alcorcón, Spain
	Not yet recruiting
Badalona, Spain
	Not yet recruiting
Barakaldo, Spain
	Not yet recruiting
Barcelona, Spain
	Not yet recruiting
Barco de Valdeorras, Spain
	Not yet recruiting
Bilbao, Spain
	Not yet recruiting
Boadilla del Monte, Spain
	Not yet recruiting
CEE, Spain
	Recruiting
Esplugues de Llobregat, Spain
	Not yet recruiting
Estella, Spain
	Not yet recruiting
Ferrol, Spain
	Not yet recruiting
Figueres, Spain
	Not yet recruiting
Getafe, Spain
	Not yet recruiting
Girona, Spain
	Not yet recruiting
Granollers, Spain
	Not yet recruiting
La Coruña, Spain
	Recruiting
Leganés, Spain
	Not yet recruiting
Lleida, Spain
	Not yet recruiting
Zumárraga, Spain
	Recruiting
Madrid, Spain
	Not yet recruiting
Mondragón, Spain
	Not yet recruiting
Monforte de Lemos, Spain
	Not yet recruiting
Móstoles, Spain
	Not yet recruiting
Ourense, Spain
	Not yet recruiting
Pamplona, Spain
	Not yet recruiting
Pontevedra, Spain
	Not yet recruiting
Reus, Spain
	Not yet recruiting
Ribeira, Spain
	Recruiting
Sabadell, Spain
	Not yet recruiting
San Lorenzo de El Escorial, Spain
	Not yet recruiting
San Sebastián, Spain
	Not yet recruiting
Tarragona, Spain
	Not yet recruiting
Terrasa, Spain
	Not yet recruiting
Tudela, Spain
	Not yet recruiting
Verín, Spain
	Recruiting
Vigo, Spain
	Not yet recruiting
Vitoria, Spain
	Not yet recruiting
Lugo, Spain

Sponsors and Collaborators

Wyeth

Investigators

Study Director:

Medical Monitor

Wyeth

More Information

Study ID Numbers:	101539
Study First Received:	September 12, 2005
Last Updated:	May 17, 2006
ClinicalTrials.gov Identifier:	NCT00227214
Health Authority:	Spain: Spanish Agency of Medicines

Study placed in the following topic categories:

Bacterial Infections
Gram-Positive Bacterial Infections
Central Nervous System Infections
Streptococcal Infections
Meningitis, Bacterial

Central Nervous System Diseases
Meningitis, Pneumococcal
Pneumococcal Infections
Meningitis

Additional relevant MeSH terms:

Nervous System Diseases
Central Nervous System Bacterial Infections

ClinicalTrials.gov processed this record on January 16, 2009